← All companies
XAGE
Longevity Health Holdings, Inc.
$0.23
+0.00 0.00%
Key statistics
from XBRL data in SEC filingsMarket cap
$557K
Revenue (TTM)
$1.79M
Net income (TTM)
-$6.83M
EPS (TTM)
$-4.06
P/E ratio
—
Dividend yield
—
Free cash flow
-$3.34M
Cash
$313K
Total assets
$1.64M
Gross margin
59.2%
52-week range
$0.21 – $2.98
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Director or officer change
Jun 4, 2026
10-Q
Quarter ended 2026-03-31
May 15, 2026
10-K
Fiscal year ended 2025-12-31
Mar 31, 2026
8-K
Entered a material agreement; Unregistered sale of equity; Director or officer change; Regulation FD disclosure
Mar 17, 2026
8-K
Terminated a material agreement
Dec 12, 2025
10-Q
Quarter ended 2025-09-30
Nov 14, 2025
8-K
Entered a material agreement
Nov 7, 2025
8-K
Delisting notice or listing-rule failure
Sep 12, 2025
10-Q
Quarter ended 2025-06-30
Aug 14, 2025
8-K
Entered a material agreement; Change in control; Other events
Jul 14, 2025
8-K
Entered a material agreement
Jun 25, 2025
10-K/A
Fiscal year ended 2024-12-31
Jun 17, 2025
8-K
Other events
May 28, 2025
8-K
Other events
May 21, 2025
8-K
Results of operations (earnings release)
May 16, 2025
10-Q
Quarter ended 2025-03-31
May 15, 2025
8-K
Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure
May 12, 2025
8-K
Entered a material agreement; Change in control; Other events
Apr 14, 2025
8-K
Delisting notice or listing-rule failure
Apr 3, 2025
10-K
Fiscal year ended 2024-12-31
Mar 31, 2025
8-K/A
Mar 31, 2025
8-K
Shareholder vote results
Mar 26, 2025
8-K
Amended charter or bylaws; Other events
Mar 10, 2025
8-K
Delisting notice or listing-rule failure
Mar 5, 2025
8-K
Director or officer change
Jan 24, 2025
8-K
Completed an acquisition or disposition; Unregistered sale of equity; Other events
Jan 16, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Jan 3, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Dec 31, 2024
8-K
Regulation FD disclosure
Nov 20, 2024
10-Q
Quarter ended 2024-09-30
Nov 14, 2024
8-K
Delisting notice or listing-rule failure
Oct 3, 2024
8-K
Delisting notice or listing-rule failure
Aug 30, 2024
10-Q
Quarter ended 2024-06-30
Aug 14, 2024
8-K
Director or officer change; Other events
Jul 29, 2024
8-K
Shareholder vote results
Jul 17, 2024
10-Q
Quarter ended 2024-03-31
May 15, 2024
10-K/A
Fiscal year ended 2023-12-31
Apr 29, 2024
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Apr 4, 2024
8-K
Completed an acquisition or disposition; Other events
Apr 1, 2024
10-K
Fiscal year ended 2023-12-31
Apr 1, 2024